Artificial Intelligence in Drug Discovery and Biotech: 2022 Recap and Key Trends

A roundup of key developments in AI drug discovery space in 2022

I am starting this weekly newsletter, “Where Tech Meets Bio“ and, together with my team at BiopharmaTrend.com, we are busy preparing the first newsletter next week. In the meantime, below is a reference to our recent industry report profiling the area of artificial intelligence in drug discovery/clinical research in 2022:

Table of contents:

• The advent of AI in drug discovery at a glance

• What is AI, and how can it boost drug research?

• AI drug discovery investment landscape, 2022

• AI-enabled biology modeling and target discovery

• Cracking structural biology with AI

• Developing small molecules using AI

• AI meets DNA-encoded libraries

• AI-driven drug design beyond small molecules

• The first wave of AI-developed drug candidates goes clinical

• Twenty most “productive” AI companies in the drug discovery space

• AI and robotized labs of the future

• Navigating clinical trial bottlenecks with AI

• AI in the contract research industry 

• Technology giants go after drug discovery and biotech

• The future of AI in drug discovery: all things "quantum"

Starting from next week, we will be providing rich content here, and many insights will be unique to this newsletter and will not be available on our website or anywhere else. Also, we will have chats here, and I will be able to answer questions in the comments on this Substack. So, consider subscribing to this newsletter to get unique industry insights about everything “tech+bio“.

See you soon!

Andrii